William Lis
Direktor/Vorstandsmitglied bei ZAI LAB LIMITED
Vermögen: 790 315 $ am 31.05.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Ya jing Chen | M | 56 | 3 Jahre | |
| Susan S. Prohaska | M | - |
Jasper Tx Corp.
 Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | 6 Jahre |
| Ying Du | M | 59 | 10 Jahre | |
| Scott Morrison | M | 66 | 3 Jahre | |
| Lina Zhang | F | - | - | |
| F. Edmondson | M | 58 | 4 Jahre | |
| Judith Shizuru | M | 68 |
Jasper Tx Corp.
Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | - |
| Peter Wirth | M | 73 | 7 Jahre | |
| Michel Vounatsos | M | 62 | 1 Jahre | |
| John Diekman | M | 81 | 7 Jahre | |
| Richard Gaynor | M | 74 | 3 Jahre | |
| Rafael Amado | M | 60 | 2 Jahre | |
| Kai Xian Chen | M | 78 | 6 Jahre | |
| Joshua Smiley | M | 54 | 2 Jahre | |
| Wing Yu Leung | F | 53 | 10 Jahre | |
| Lonnie Moulder | M | 66 | 5 Jahre | |
| Jonathan A. Barr | M | - | 3 Jahre | |
| James Yan | M | 60 | 4 Jahre | |
| Jonathan Wang | M | 42 | 10 Jahre | |
| Harald Reinhart | M | 72 | 7 Jahre | |
| Anna Phil | M | 36 |
Jasper Tx Corp.
Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | 5 Jahre |
| Kurt von Emster | M | 56 |
Jasper Tx Corp.
Jasper Tx Corp. BiotechnologyHealth Technology Jasper Tx Corp. operates as a biotechnology company. It engages in the clinical development of novel therapies. The company was founded by Susan S. Prohaska and Judith Shizuru and is headquartered in Mountain View, CA. | 5 Jahre |
| Li Ni Ou Yang | F | - | 2 Jahre | |
| Ann Beasley | F | - | 4 Jahre | |
| Peter Huang | M | - | 2 Jahre | |
| Ning Xu | M | 59 | 10 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Tao Fu | M | 52 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 12 Jahre |
| James Topper | M | 62 | 2 Jahre | |
| Todd J. Lorenz | M | 70 |
COR Therapeutics, Inc.
 COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 7 Jahre |
| Raj Shah | M | 46 | 2 Jahre | |
| Christine Siu | F | 47 | 3 Jahre | |
| Laura Brege | F | 66 | 5 Jahre | |
| Michael M. Kitt | M | 73 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 12 Jahre |
| Eric Aguiar | M | 62 | 2 Jahre | |
| Nicholas G. Galakatos | M | 66 | 12 Jahre | |
| Robert M. Califf | M | 72 | 3 Jahre | |
| Ali Satvat | M | 46 | 3 Jahre | |
| Jean George | F | 66 | 8 Jahre | |
| W. Richey Neuman | M | - | 3 Jahre | |
| Russell C. Hirsch | M | 62 | 10 Jahre | |
| Dennis Fenton | M | 72 | 5 Jahre | |
| Jan Egbert de Vries | M | 80 |
Tr1x, Inc.
 Tr1x, Inc. Miscellaneous Commercial ServicesCommercial Services Tr1x, Inc. is an American biotechnology company. The company was founded by Jan Egbert de Vries. Jan Egbert de Vries has been the CEO since incorporation. | - |
| Hollings Renton | M | 77 | 10 Jahre | |
| John Johnson | M | 66 | - | |
| Duke Rohlen | M | 56 | 1 Jahre | |
| John J. Schembri | M | 62 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 4 Jahre |
| John Moriarty | M | 56 | 2 Jahre | |
| Mark W. Gossett | M | - | - | |
| John Curnutte | M | 72 | 8 Jahre | |
| Peggy Phillips | F | 70 | 7 Jahre | |
| Uma Sinha | M | 67 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 22 Jahre |
| Charles Homcy | M | 75 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 14 Jahre |
| David Stump | M | 74 | - | |
| Jean-Jacques Bienaimé | M | 70 | 4 Jahre | |
| Suzanne Hooper | F | 58 | 1 Jahre | |
| Stacy Markel | F | 59 | 3 Jahre | |
| Kala Subramanian | M | 57 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | 2 Jahre |
| Alexander M. Gold | M | - | 4 Jahre | |
| Yong Jiang Hei | M | 61 | 3 Jahre | |
| John B. Russell | M | 51 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 2 Jahre |
| Patrick A. Broderick | M | 66 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 3 Jahre |
| Ahmad Sadr | M | - | 1 Jahre | |
| John H. Lawrence | M | - | 1 Jahre | |
| R. Ramelmeier | M | 62 | 3 Jahre | |
| Ki Chul Cho | M | 46 | 5 Jahre | |
| Yi Liang | M | 53 | 6 Jahre | |
| Ernie Meyer | M | 60 | - | |
| Mike Ouimette | M | 51 | 6 Jahre | |
| Valeria Fantin | M | - | 1 Jahre | |
| Karl Hsu | M | - | - | |
| Angela Jiang | F | - | - | |
| Lina Zhang | F | - | - | |
| Michael Berry | M | 59 | 2 Jahre | |
| Luca Di Noto | M | - | 5 Jahre | |
| Ron Aldridge | M | - | - | |
| Jeet Mahal | M | 52 | 11 Jahre | |
| Walter H. Bee | M | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 4 Jahre |
| Raymond Furey | M | 56 | 3 Jahre | |
| Randall M. St. Laurent | M | 63 | - | |
| Randall Kaye | M | 61 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 2 Jahre |
| Santosh Vetticaden | M | 65 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 4 Jahre |
| Sarvajit Chakravarty | M | 58 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 14 Jahre |
| Daron Evans | M | 50 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 2 Jahre |
| Peter M. Strumph | M | 59 | - | |
| Mark D. Perrin | M | 67 |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 6 Jahre |
| Richard B. Brewer | M | 72 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 6 Jahre |
| George F. Schreiner | M | 74 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 9 Jahre |
| Farah Champsi | F | 62 | 8 Jahre | |
| Matthew R. Hooper | M | 66 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 6 Jahre |
| Russell Cox | M | 60 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 4 Jahre |
| F. Allan Gordon | M | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 3 Jahre |
| George T. Jue | M | 71 |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 5 Jahre |
| Ho Young Huh | M | 54 | - | |
| Dennis O. Driver | M | - |
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | 6 Jahre |
| Glenn Michelson | M | 59 | 1 Jahre | |
| Daniel D. Gretler | M | - |
COR Therapeutics, Inc.
COR Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction | 7 Jahre |
| Debanjan Ray | M | 46 | 2 Jahre | |
| Anjali Pandey | M | - | 15 Jahre | |
| Alan Sandler | M | 67 | 2 Jahre | |
| David Parry | M | - | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 70 | 70,00% |
| Cayman Islands | 31 | 31,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- William Lis
- Persönliches Netzwerk
